Highlights KPC Pharmaceuticals,Inc

Equities

600422

CNE0000015P8

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-05-15 EDT			5-day change	1st Jan Change
22.8 ^CNY	-2.06%		-0.96%	+9.30%

04-19	KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	Kunyao Group Receives Clinical Trial Approval for FMF Drug	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
KPC Pharmaceuticals,Inc Proposes Cash Dividend	03-21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	03-21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	23-08-29	MT
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	23-04-27	MT
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	22-12-29	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
CR Sanjiu Medical & Pharma to Buy 28% Stake in KPC Pharma For $430 Million	22-05-09	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. agreed to acquire 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited for CNY 2.9 billion.	22-05-07	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-15	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-18	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-21	CI
Kpc Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-13	CI
Kpc Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-15	CI
New Hope Healthcare Nanjing Investment Center (Limited Partnership) signed an agreement to acquire 3.7% stake in Nanjing Weili Zhibo Biotechnology Co., Ltd. from KPC Pharmaceuticals, Inc. for CNY 30 million.	21-03-15	CI
Kpc Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights KPC Pharmaceuticals,Inc

Equities

600422

CNE0000015P8

Highlights

Filters